Evidence map›Paper›PMID 41766230›Full record

ArticleThe American journal of case reports2026

Late-Onset Adenovirus-Induced Achalasia in a Kidney Transplant Recipient: A Case Report.

Ali H Alshaqaq, Mohamed E Elrggal, Mohammed S Aljawad, Mahmoud A Ahmed, Abdulrazack A Amir, Ahmed M Alkhunaizi

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ali H AlshaqaqNephrology Division, Department of Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Mohamed E ElrggalNephrology Division, Department of Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.ORCID 0000-0002-7049-4777
Mohammed S AljawadGastroenterology Division, Department of Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Mahmoud A AhmedNephrology Division, Department of Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Abdulrazack A AmirNephrology Division, Department of Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Ahmed M AlkhunaiziNephrology Division, Department of Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Adenovirus infection in kidney transplant recipients, although rare, represents a potentially life-threatening complication that typically manifests early after transplantation. Late-onset adenovirus infection is uncommon and presents substantial diagnostic and therapeutic challenges, particularly in cases of atypical organ involvement. Esophageal involvement is exceptionally rare and has not been extensively characterized in solid-organ transplant recipients. CASE REPORT A 60-year-old male kidney transplant recipient presented with a 1-week history of dysuria, gross hematuria, diarrhea, and worsening graft function 5 years after transplantation. Progressive dysphagia developed after admission. Laboratory testing confirmed adenovirus infection in the blood, with a viral load of 779 000 IU/mL. Adenovirus was also detected in urine and stool samples, whereas cytomegalovirus and polyomavirus testing yielded negative results. Gastroscopy and barium swallow studies demonstrated achalasia-like features. Esophageal biopsy specimens did not show viral cytopathic changes. Management consisted of immunosuppression reduction, intravenous immunoglobulin administration, and low-dose cidofovir therapy. Clinical and virologic recovery was achieved within 3 weeks, with complete resolution of gastrointestinal symptoms and stabilization of graft function. CONCLUSIONS This case underscores the atypical late presentation of adenovirus infection in a kidney transplant recipient and illustrates the potential for extremely rare esophageal involvement manifesting as achalasia. Despite the absence of direct viral confirmation in esophageal tissue, the clinical course and therapeutic response support adenovirus as the most likely etiology. Early recognition, confirmation by polymerase chain reaction testing, and timely immunosuppression adjustment combined with antiviral therapy are essential to optimize patient outcomes.

Indexed as

Adenoviridae InfectionsEsophageal AchalasiaKidney TransplantationAntiviral AgentsHumansMaleMiddle AgedAntiviral Agents

Identifiers

PMID41766230
PMCPMC12964976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.